4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-25-011679
Chief Technical Officer sold 794 shares at an average $57.51 ($45,663)
- Chief Technical Officer acquired 4,218 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shulman Joseph Chief Technical Officer | 2025-02-09 | Option exercise 10b5-1 | +2,656 | 5,313 | D | ||
| Shulman Joseph Chief Technical Officer | 2025-02-11 | Option exercise 10b5-1 | +1,562 | 6,875 | D | ||
| Shulman Joseph Chief Technical Officer | 2025-02-11 | Sale 10b5-1 | −791 | $57.51 | $45,490 | 6,084 | D |
| Shulman Joseph Chief Technical Officer | 2025-02-11 | Sale 10b5-1 | −3 | $57.54 | $173 | 6.08 | D |
| Derivatives | |||||||
| Shulman Joseph Chief Technical Officer | 2025-02-09 | Option exercise · Restricted Stock Units 10b5-1 | −2,656 | 2,656 | D | ||
| Shulman Joseph Chief Technical Officer | 2025-02-11 | Option exercise · Restricted Stock Units 10b5-1 | −1,562 | 0 | D | ||
| Open-market sales · 794 sh · avg $57.51 · $45,663 | |||||||
Loading xslF345X05/tm256299-4_4seq1.xml…